About Eli Wallace
Eli Wallace is a chief executive officer and director at BridgeBio Oncology Therapeutics.
Form D filings name Eli Wallace as CEO at TheRas.
Eli Wallace reports to the SEC as a director or officer of 1 public company.
Eli Wallace first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Eli Wallace in the role, so the role may have started earlier or lasted longer.
BI
BridgeBio Oncology Therapeutics, Inc.
Chief Executive Officer and director
2025 – 2026 · Public company (BBOT)
Key Colleagues at Startups
The people Eli Wallace works with at each company, as listed on that company's latest Form D.
TheRas, Inc. · Form D, May 15, 2024
MD
Michelle Doig
Director
IE
Idan Elmelech
Executive officer
PB
Pedro Beltran
Executive officer
FM
Frank McCormick
Director
NK
Neil Kumar
Director
RK
Raymond Kelleher
Director